FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3196212664> ?p ?o ?g. }

• W3196212664 abstract "Abstract Background Coronavirus disease 2019 (COVID-19) pneumonitis associated with severe respiratory failure is associated with high mortality. The pathogenesis of COVID-19 is associated with microembolism or microvascular endothelial injuries. Here, we report that syndecan-1 (SDC-1), a component of the endothelial glycocalyx, may be a biomarker of severity classification for COVID-19 related to endothelial injury. Methods and analysis We analyzed the data of COVID-19 patients for 1 year from February 2020 at Yokohama City University Hospital and Yokohama City University Medical Center Hospital. We selected COVID-19 patients who required admission care, including intensive care, and analyzed the classification of severe and critical COVID-19 retrospectively, using various clinical data and laboratory data with SDC-1 by ELISA. Results We analyzed clinical and laboratory data with SDC-1 in five severe COVID-19 and ten critical COVID-19 patients. In the two groups, their backgrounds were almost the same. In laboratory data, the LDH, CHE, and CRP levels showed significant differences in each group ( P = 0.032, P < 0.0001, and P = 0.007, respectively) with no significant differences in coagulation-related factors (platelet, PT-INR, d-dimer, ISTH score; P = 0.200, 0.277, 0.655, and 0.36, respectively). For the clinical data, the SOFA score was significantly different from admission day to day 14 of admission ( p < 0.0001). The SDC-1 levels of critical COVID-19 patients were significantly higher on admission day and all-time course compared with the levels of severe COVID-19 patients ( P = 0.009 and P < 0.0001, respectively). Conclusions Temporal change of SDC-1 levels closely reflect the severity of COVID-19, therefore, SDC-1 may be a therapeutic target and a biomarker for the severity classification of Covid-19." @default.
• W3196212664 created "2021-08-30" @default.
• W3196212664 creator A5000702371 @default.
• W3196212664 creator A5011761462 @default.
• W3196212664 creator A5016103276 @default.
• W3196212664 creator A5017074101 @default.
• W3196212664 creator A5043718414 @default.
• W3196212664 creator A5045067468 @default.
• W3196212664 creator A5047729214 @default.
• W3196212664 creator A5058772543 @default.
• W3196212664 creator A5069506219 @default.
• W3196212664 creator A5075686831 @default.
• W3196212664 creator A5076041404 @default.
• W3196212664 creator A5076826337 @default.
• W3196212664 creator A5077270726 @default.
• W3196212664 creator A5086658242 @default.
• W3196212664 date "2021-08-16" @default.
• W3196212664 modified "2023-09-27" @default.
• W3196212664 title "Temporal change in Syndecan-1 as a therapeutic target and a biomarker for the severity classification of COVID-19" @default.
• W3196212664 cites W1578062386 @default.
• W3196212664 cites W2033093592 @default.
• W3196212664 cites W2040242558 @default.
• W3196212664 cites W2127666633 @default.
• W3196212664 cites W2159959764 @default.
• W3196212664 cites W2522381044 @default.
• W3196212664 cites W2581605534 @default.
• W3196212664 cites W2763610984 @default.
• W3196212664 cites W2884516608 @default.
• W3196212664 cites W2901288830 @default.
• W3196212664 cites W2905635461 @default.
• W3196212664 cites W2915852744 @default.
• W3196212664 cites W2947991270 @default.
• W3196212664 cites W2955444629 @default.
• W3196212664 cites W3001118548 @default.
• W3196212664 cites W3007829007 @default.
• W3196212664 cites W3008461878 @default.
• W3196212664 cites W3009314935 @default.
• W3196212664 cites W3009885589 @default.
• W3196212664 cites W3015863623 @default.
• W3196212664 cites W3015886046 @default.
• W3196212664 cites W3015946392 @default.
• W3196212664 cites W3016123694 @default.
• W3196212664 cites W3020773974 @default.
• W3196212664 cites W3022187628 @default.
• W3196212664 cites W3023873927 @default.
• W3196212664 cites W3027918021 @default.
• W3196212664 cites W3028615142 @default.
• W3196212664 cites W3029656471 @default.
• W3196212664 cites W3031456278 @default.
• W3196212664 cites W3038036631 @default.
• W3196212664 cites W3041374361 @default.
• W3196212664 cites W3042692915 @default.
• W3196212664 cites W3080462543 @default.
• W3196212664 cites W3080743360 @default.
• W3196212664 cites W3086808601 @default.
• W3196212664 cites W3089651755 @default.
• W3196212664 cites W3125333254 @default.
• W3196212664 cites W3152766679 @default.
• W3196212664 cites W3153935161 @default.
• W3196212664 doi "https://doi.org/10.1186/s12959-021-00308-4" @default.
• W3196212664 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8366156" @default.
• W3196212664 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34399775" @default.
• W3196212664 hasPublicationYear "2021" @default.
• W3196212664 type Work @default.
• W3196212664 sameAs 3196212664 @default.
• W3196212664 citedByCount "17" @default.
• W3196212664 countsByYear W31962126642022 @default.
• W3196212664 countsByYear W31962126642023 @default.
• W3196212664 crossrefType "journal-article" @default.
• W3196212664 hasAuthorship W3196212664A5000702371 @default.
• W3196212664 hasAuthorship W3196212664A5011761462 @default.
• W3196212664 hasAuthorship W3196212664A5016103276 @default.
• W3196212664 hasAuthorship W3196212664A5017074101 @default.
• W3196212664 hasAuthorship W3196212664A5043718414 @default.
• W3196212664 hasAuthorship W3196212664A5045067468 @default.
• W3196212664 hasAuthorship W3196212664A5047729214 @default.
• W3196212664 hasAuthorship W3196212664A5058772543 @default.
• W3196212664 hasAuthorship W3196212664A5069506219 @default.
• W3196212664 hasAuthorship W3196212664A5075686831 @default.
• W3196212664 hasAuthorship W3196212664A5076041404 @default.
• W3196212664 hasAuthorship W3196212664A5076826337 @default.
• W3196212664 hasAuthorship W3196212664A5077270726 @default.
• W3196212664 hasAuthorship W3196212664A5086658242 @default.
• W3196212664 hasBestOaLocation W31962126641 @default.
• W3196212664 hasConcept C126322002 @default.
• W3196212664 hasConcept C185592680 @default.
• W3196212664 hasConcept C2779134260 @default.
• W3196212664 hasConcept C2781197716 @default.
• W3196212664 hasConcept C30036603 @default.
• W3196212664 hasConcept C3008058167 @default.
• W3196212664 hasConcept C524204448 @default.
• W3196212664 hasConcept C55493867 @default.
• W3196212664 hasConcept C555175668 @default.
• W3196212664 hasConcept C71924100 @default.
• W3196212664 hasConceptScore W3196212664C126322002 @default.
• W3196212664 hasConceptScore W3196212664C185592680 @default.
• W3196212664 hasConceptScore W3196212664C2779134260 @default.
• W3196212664 hasConceptScore W3196212664C2781197716 @default.
• W3196212664 hasConceptScore W3196212664C30036603 @default.
• W3196212664 hasConceptScore W3196212664C3008058167 @default.

• next